SEC Tracker
Get the app

Glucotrack GCTK

Glucotrack faces Nasdaq delisting

Nasdaq bid price delisting decision, Item 3.01 Listing standards notice

Form
8-K
Filed
Importance
Major
  1. Received delisting notice from Nasdaq for failing bid price rule
  2. Closing bid price was $0.87 on Oct 14, 2026
  3. Shares to be suspended on Oct 30, 2026
  4. Plans to apply for OTCID market listing

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Glucotrack files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 3841 and related industry codes: the same peer list as the financial tables.

  1. Aethlon Medical AEMD public float $6M, Sep 30, 2025
  2. Family Office of America FOFA public float $6M, Jun 30, 2025
  3. Odyssey Health ODYY public float $6M, Jan 31, 2026
  4. Autonomix Medical AMIX public float $6M, Sep 30, 2025
  5. Sonoma Pharmaceuticals SNOA public float $6M, Sep 30, 2025